These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 6445735)

  • 21. [Comparative activity of azlocillin on Pseudomonas species excluding Pseudomonas aeruginosa].
    Monteil H; Peladan F; Zinsius M
    Presse Med; 1984 Mar; 13(13):780-4. PubMed ID: 6324160
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Apalcillin [PC-904]: spectrum of activity and beta-lactamase hydrolysis/inhibition.
    Barry AL; Jones RN; Thornsberry C
    Diagn Microbiol Infect Dis; 1985 Jan; 3(1):7-17. PubMed ID: 3871382
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The acylampicillins: mezlocillin, piperacillin, and azlocillin.
    Drusano GL; Schimpff SC; Hewitt WL
    Rev Infect Dis; 1984; 6(1):13-32. PubMed ID: 6369480
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synergism of azlocillin, mezlocillin, piperacillin in combination with tobramycin against Klebsiella and Pseudomonas.
    Downs JT; Andriole VT; Ryan JL
    Yale J Biol Med; 1986; 59(1):11-6. PubMed ID: 3634545
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Studies on the antibacterial activity of two new acylureidopenicillins, mezlocillin and azlocillin.
    Soares LA; Trabulsi LR
    Arzneimittelforschung; 1979; 29(12a):1932-4. PubMed ID: 543893
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Comparative activity of cefsulodin on Pseudomonas aeruginosa, Acinetobacter and Enterobacteriaceae (author's transl)].
    Courtieu AL; Drugeon HB; Bryskier A; Chung SS; Reynaud A
    Pathol Biol (Paris); 1982 Jun; 30(6):432-9. PubMed ID: 6810287
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Antibacterial activity of apalcillin against 300 strains of enterobacteria].
    Coulet M; Forey F; Brun Y; Fleurette J
    Pathol Biol (Paris); 1983 May; 31(5):311-8. PubMed ID: 6353323
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative review of two new wide-spectrum penicillins: mezlocillin and piperacillin.
    Russo J; Russo ME
    Clin Pharm; 1982; 1(3):207-16. PubMed ID: 6224627
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Bacteriostatic activity of apalcillin on Gram-negative bacilli and strict anaerobic bacteria. Multicenter study].
    Quentin C; Auzerie J; Bebear C; Acar JF; Kitzis MD; Avril JL; Moillo-Batt A; Shacoori Z; Bergogne-Berezin E; Joly-Guillou ML
    Pathol Biol (Paris); 1984 May; 32(5):301-6. PubMed ID: 6429608
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative activities of the beta-lactamase inhibitors YTR 830, clavulanate and sulbactam combined with extended-spectrum penicillins against ticarcillin-resistant Enterobacteriaceae and pseudomonads.
    Jacobs MR; Aronoff SC; Johenning S; Yamabe S
    J Antimicrob Chemother; 1986 Aug; 18(2):177-84. PubMed ID: 3019984
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Azlocillin and mezlocillin: new ureido penicillins.
    Fu KP; Neu HC
    Antimicrob Agents Chemother; 1978 Jun; 13(6):930-8. PubMed ID: 677860
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Agar (disk) diffusion test susceptibility of clinical isolates of Pseudomonas aeruginosa to azlocillin, cefotaxime, cefsulodin, lamoxactam, mezlocillin, and piperacillin.
    Traub WH
    Chemotherapy; 1982; 28(4):257-60. PubMed ID: 6288329
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of inoculum size on the activity of carboxy- and ureido-penicillins and effects of combinations of ureido-penicillins with aminoglycosides against resistant Pseudomonas aeruginosa.
    Watanakunakorn C
    J Antimicrob Chemother; 1986 Jan; 17(1):91-5. PubMed ID: 3081474
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multicenter in vitro comparison of piperacillin and nine other antibacterials against 1,629 clinical isolates.
    Greenberg RN; Bowne DB; Gelfand M; Sathe SS
    Clin Ther; 1990; 12(1):61-70. PubMed ID: 2183941
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative antibacterial activity of azlocillin, mezlocillin, carbenicillin and ticarcillin and relative stability to beta-lactamases of pseudomonas aeruginosa and klebsiella aerogenes.
    Basker MJ; Edmondson RA; Sutherland R
    Infection; 1979; 7(2):67-73. PubMed ID: 108220
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The effect of sulbactam on the in vitro activity of mezlocillin, piperacillin and cefotaxime].
    Bauernfeind A; Grimm H; Klietmann W; Opferkuch W; Werner H
    Arzneimittelforschung; 1991 Aug; 41(8):831-8. PubMed ID: 1781806
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Study of in vitro antibacterial activity of 19 antimicrobial agents against Pseudomonas aeruginosa.
    Wang R; Sun XD; Cai QM
    Chin Med J (Engl); 1989 Apr; 102(4):313-8. PubMed ID: 2507247
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Pseudomonas aeruginosa: acquired in vitro resistance to beta-lactams].
    Thabaut A; Meyran M
    Pathol Biol (Paris); 1983 May; 31(5):387-91. PubMed ID: 6413939
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro activity of apalcillin compared with that of other new penicillins and anti-Pseudomonas cephalosporins.
    Neu HC; Labthavikul P
    Antimicrob Agents Chemother; 1982 Jun; 21(6):906-11. PubMed ID: 6981375
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of in vitro susceptibilities among gram-negative rods.
    Westblom TU; Midkiff BR
    W V Med J; 1989 Jul; 85(7):279-80. PubMed ID: 2756707
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.